North America

One of the largest groups for doctors in the U.S. is calling for new health care oversight in an effort to counter high prescription drug costs.

As part of the conversation on options for universal pharmacare in Canada, The Conference Board of Canada examined patients’ access to necessary diabetes medications.

A West Island woman living with cystic fibrosis says the prohibitive price of a drug is costing Canadian lives.

Speaker Nancy Pelosi and a host of both Democrats and Republicans want the federal government to apply price controls to prescription drugs. Their proposals are based on two fantasies.

A Look at ICER’s Unsupported Drug Price Increase Report

Two regulations advance the Trump Administration’s commitment to increasing price transparency.

Stakeholders' Views of Risk Evaluation and Mitigation Strategies Differ

Some of President Donald Trump’s signature proposals to lower drug costs have come under fire from conservative groups, many of which received funding from the pharmaceutical industry last year.

It is expansive and bold, and has brought some excitement to the progressive core of the Democratic Party.

Her strategy of slowly phasing in government health insurance for everyone reveals a fundamental divide between her and Bernie Sanders.

Drug pricing regulations would not decimate the pharmaceutical industry.

President Trump has made drug-pricing transparency a centrepiece of his health care agenda.

A gradual shift underway in Canada where biosimilars have been slowly catching on.

President Trump wants the U.S. to pay less than other countries for some prescription drugs covered by Medicare — a benchmark even lower than what congressional Democrats want.

Staff Report Committee on Oversight and Reform U.S. House of Representatives